Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Jun 21, 2022, 13:30 ET
Share this article
DUBLIN, June 21, 2022 /PRNewswire/ — The "Global 3D Cardiac Mapping Market (2022-2027) by Type, Indication, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com’s offering.
The Global 3D Cardiac Mapping Market is estimated to be USD 75.35 Mn in 2022 and is projected to reach USD 133.51 Mn by 2027, growing at a CAGR of 12.12%.

Market dynamics are forces that impact the prices and behaviors of the Global 3D Cardiac Mapping Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations
The Global 3D Cardiac Mapping Market is segmented based on Technology, End-User, and Geography.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are Medtronic, Boston Scientific, Microport Scientific, APN Health, Coremap, Kardium, Catheter Precision, Epmap-System, etc.

Countries Studied
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis
 Why buy this report?
Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Surge in Prevalence of Cardiac Arrhythmias
4.1.2 Growth in Preference for Minimally Invasive Procedures
4.1.3 Growth in the Geriatric Population
4.2 Restraints
4.2.1 High Cost of 3D Cardiac Mapping Systems
4.2.2 Unfavorable Regulatory Scenario
4.3 Opportunities
4.3.1 Focus on Launch of Innovative Products
4.3.2 Emergence of AI and ML Technologies to Boost the 3D Content Accuracy
4.4 Challenges
4.4.1 Availability of Alternative Technologies

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global 3D Cardiac Mapping Market, By Technology
6.1 Introduction
6.2 Electroanatomical Mapping
6.3 Basket Catheter Mapping
6.4 Real-Time Positional Management (Cardiac Pathways) EP System

7 Global 3D Cardiac Mapping Market, By End-User
7.1 Introduction
7.2 Hospitals &Clinics
7.3 Diagnostics Centers

8 Americas’ 3D Cardiac Mapping Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas

9 Europe’s 3D Cardiac Mapping Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe

10 Middle East and Africa’s 3D Cardiac Mapping Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA

11 APAC’s 3D Cardiac Mapping Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 Biosense Webster (A Johnson & Johnson Company)
13.2 Abbott Laboratories
13.3 Medtronic
13.4 Boston Scientific
13.5 Microport Scientific
13.6 EP Solutions
13.7 Koninklijke Philips
13.8 Lepu Medical
13.9 Biotronik
13.10 Angiodynamics
13.11 Biosig Technologies
13.12 APN Health
13.13 Coremap
13.14 Kardium
13.15 Catheter Precision
13.16 Epmap-System

14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/y37ia0
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source